Antivenom efficacy or effectiveness: the Australian experience.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Toxicology

• Publication date

  2010-02-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.tox.2009.09.013PMID 19782716
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An in vivo comparison of the efficacy of CSL box jellyfish antivenom with antibodies raised against nematocyst-derived Chironex fleckeri venom.

  2009cited by this paper
• Antivenom for critically ill children with neurotoxicity from scorpion stings.

  2009cited by this paper
• A cell-based assay for screening of antidotes to, and antivenom against Chironex fleckeri (box jellyfish) venom.

  2009cited by this paper
• Commercial monovalent antivenoms in Australia are polyvalent.

  2009cited by this paper
• Procoagulant Snake Toxins: Laboratory Studies, Diagnosis, and Understanding Snakebite Coagulopathy

  2009cited by this paper
• Failure of antivenom to improve recovery in Australian snakebite coagulopathy.

  2009cited by this paper
• A comparison of serum antivenom concentrations after intravenous and intramuscular administration of redback (widow) spider antivenom.

  2008cited by this paper
• Current use of Australian snake antivenoms and frequency of immediate‐type hypersensitivity reactions and anaphylaxis

  2008cited by this paper
• Characterization of a new polyvalent antivenom (Antivipmyn Africa) against African vipers and elapids.

  2008cited by this paper
• A model for venom-induced consumptive coagulopathy in snake bite.

  2008cited by this paper
• Medical aspects of spider bites.

  2008cited by this paper
• Neurotoxins From Australo-Papuan Elapids: A Biochemical and Pharmacological Perspective

  2008cited by this paper
• A randomised controlled trial of intramuscular vs. intravenous antivenom for latrodectism--the RAVE study.

  2008cited by this paper
• The Global Burden of Snakebite: A Literature Analysis and Modelling Based on Regional Estimates of Envenoming and Deaths

  2008cited by this paper
• Thrombotic microangiopathy from Australian brown snake (Pseudonaja) envenoming

  2007cited by this paper
• Cross-neutralisation of Australian brown and tiger snake venoms with commercial antivenoms: Cross-reactivity or antivenom mixtures?

  2007cited by this paper
• Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies.

  2007cited by this paper
• Clinically applicable laboratory end‐points for treating snakebite coagulopathy

  2006cited by this paper
• Enzyme immunoassays in brown snake (Pseudonaja spp.) envenoming: detecting venom, antivenom and venom-antivenom complexes.

  2006cited by this paper
• The Medical

  2006cited by this paper
• Clinical trials in toxinology: More than a discussion between friends?

  2006cited by this paper
• Treatment of snakebite in Australia: the current evidence base and questions requiring collaborative multicentre prospective studies.

  2006cited by this paper
• Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without beta-propiolactone, in the treatment of Bothrops asper bites in Colombia.

  2006cited by this paper
• A double‐blind, randomized trial of intravenous versus intramuscular antivenom for Red‐back spider envenoming

  2005cited by this paper
• Funnel‐web spider bite: a systematic review of recorded clinical cases

  2005cited by this paper
• Neurotoxic marine poisoning.

  2005cited by this paper
• ANTIVENOM DEVELOPMENT IN AUSTRALIA

  2005cited by this paper
• Prospective study of Chironex fleckeri and other box jellyfish stings in the “Top End” of Australia's Northern Territory

  2005cited by this paper
• High-dose anti-snake venom versus low-dose anti-snake venom in the treatment of poisonous snake bites--a critical study.

  2004cited by this paper
• Antivenom dosing in 35 patients with severe brown snake (Pseudonaja) envenoming in Western Australia over 10 years

  2004cited by this paper
• The in vivo cardiovascular effects of box jellyfish Chironex fleckeri venom in rats: efficacy of pre-treatment with antivenom, verapamil and magnesium sulphate.

  2004cited by this paper
• Preclinical testing of three South American antivenoms against the venoms of five medically-important Peruvian snake venoms.

  2004cited by this paper
• Crotaline snake bite in the Ecuadorian Amazon: randomised double blind comparative trial of three South American polyspecific antivenoms

  2004cited by this paper
• Marine Antivenoms

  2003cited by this paper
• Suspected snakebite: one year prospective study of emergency department presentations.

  2003cited by this paper
• Clinical Toxinology—Where Are We Now?

  2003cited by this paper
• Antivenom Treatment in Arachnidism

  2003cited by this paper
• Pharmacokinetic-Pharmacodynamic Relationships of Immunoglobulin Therapy for Envenomation

  2003cited by this paper
• Five years of snake envenoming in far north Queensland.

  2003cited by this paper
• Snake Antivenoms

  2003cited by this paper
• The African challenge.

  2002cited by this paper
• The African challenge.

  2002cited by this paper
• Spiders of medical importance in the Asia–Pacific: Atracotoxin, latrotoxin and related spider neurotoxins

  2002cited by this paper
• Failure of intramuscular antivenom in Red-back spider envenoming.

  2002cited by this paper
• Common krait (Bungarus caeruleus) bite in Anuradhapura, Sri Lanka: a prospective clinical study, 1996–98

  2002cited by this paper
• A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States.

  2001cited by this paper
• Red-back spider (Latrodectus hasselti) antivenom prevents the toxicity of widow spider venoms.

  2001cited by this paper
• An open, randomized comparative trial of two antivenoms for the treatment of envenoming by Sri Lankan Russell's viper (Daboia russelii russelii).

  2001cited by this paper
• Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline Fab antivenom.

  2001cited by this paper
• Snakebite in tropical Australia, Papua New Guinea and Irian Jaya

  2000cited by this paper
• Treatment of scorpion envenoming should include both a potent specific antivenom and support of vital functions.

  2000cited by this paper
• Snake venom metalloproteinases: their role in the pathogenesis of local tissue damage.

  2000cited by this paper
• Serotherapy in scorpion envenomation: a randomised controlled trial.

  1999cited by this paper
• Is antivenom the most successful therapy in scorpion victims?

  1999cited by this paper
• Doctor Albert Calmette 1863-1933: founder of antivenomous serotherapy and of antituberculous BCG vaccination.

  1999cited by this paper
• Snake venom hemorrhagins.

  1999cited by this paper
• Brown Snakes (Pseudonaja Genus): Venom Yields, Prothrombin Activator Neutralization and Implications Affecting Antivenom Usage

  1998cited by this paper
• Pharmacokinetics of 125I-labelled IgG, F(ab')2 and Fab fractions of scorpion and snake antivenins: merits and potential for therapeutic use.

  1998cited by this paper
• Venoms, antivenoms and immunotherapy.

  1998cited by this paper
• Spontaneous recovery from severe neurotoxic envenoming by a Malayan krait Bungarus candidus (linnaeus) in Thailand

  1997cited by this paper
• Efficacy and Potency of Antivenoms in Neutralizing the Procoagulant Effects of Australian Snake Venoms in Dog and Human Plasma

  1996cited by this paper
• Snake bites by the Papuan taipan (Oxyuranus scutellatus canni): paralysis, hemostatic and electrocardiographic abnormalities, and effects of antivenom.

  1995cited by this paper
• The efficacy of antivenom in the treatment of bites by the Papuan taipan (Oxyuranus scutellatus canni).

  1995cited by this paper
• Coagulopathy following bites by the Papuan taipan (Oxyuranus scutellatus canni)

  1995cited by this paper
• Fatal Brown Snake (Pseudonaja textilis) Envenomation Despite the use of Antivenom

  1993cited by this paper
• The Efficacy of Antivenom in Prevention of Cardiovascular Depression and Coagulopathy Induced by Brown Snake (Pseudonaja) Species Venom

  1991cited by this paper
• Envenoming by the common krait (Bungarus caeruleus) and Sri Lankan cobra (Naja naja naja): efficacy and complications of therapy with Haffkine antivenom.

  1990cited by this paper
• Myotoxic components of snake venoms: their biochemical and biological activities.

  1990cited by this paper
• Paralysis, rhabdomyolysis and haemolysis caused by bites of Russell's viper (Vipera russelli pulchella) in Sri Lanka: failure of Indian (Haffkine) antivenom.

  1988cited by this paper
• Bites by Russell's viper (Vipera russelli siamensis) in Burma: haemostatic, vascular, and renal disturbances and response to treatment.

  1985cited by this paper
• Funnel‐web spider (Atrax robustus) antivenom in the treatment of human envenomation

  1984cited by this paper
• Effect of metoclopramide in guinea-pig ileum longitudinal muscle: evidence against dopamine-mediation.

  1982cited by this paper
• Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria.

  1977cited by this paper
• Infertility in male pesticide workers.

  1977cited by this paper
• Necrosis, haemorrhage and complement depletion following bites by the spitting cobra (Naja nigricollis).

  1976cited by this paper
• RED BACK SPIDER BITE IN AUSTRALIA: AN ANALYSIS OF 167 CASES

  1961cited by this paper

• Haemotoxicity of snakes: a review of pathogenesis, clinical manifestations, novel diagnostics and challenges in management.

  2025cites this paper
• Comparative Clinical Observations Following Introduction of a New Polyvalent Antivenom For Snakebite Envenoming in Northern Nigeria.

  2025cites this paper
• Snake Venom and its Effects on Animal Health

  2025cites this paper
• Long-Term Clinical Outcomes of Rattlesnake Envenomation in Arizona Following Treatment With Crofab vs Anavip: A Retrospective Observational Study

  2025cites this paper
• Hump-Nosed Pit Viper (Hypnale hypnale) Venom-Induced Irreversible Red Blood Cell Aggregation, Inhibition by Monovalent Anti-Venom and N-Acetylcysteine

  2024cites this paper
• Optimization of Venom-Induced Consumption Coagulopathy Management with Blood Component Transfusion

  2024cites this paper
• Exploring the Venom Gland Transcriptome of Bothrops asper and Bothrops jararaca: De Novo Assembly and Analysis of Novel Toxic Proteins

  2024cites this paper
• Taking the sting out of scorpions: Electrophysiological investigation of the relative efficacy of three antivenoms against medically significant Centruroides species.

  2024cites this paper
• Neurotoxic Snakebites in Africa: Clinical Implications, Therapeutic Strategies, and Antivenom Efficacy.

  2024cites this paper
• Reproductive performance of freshwater snail, Helisoma duryi under the effect of bulk and nano zinc oxide.

  2024cites this paper
• Immunological Cross-Reactivity and Preclinical Assessment of a Colombian Anticoral Antivenom against the Venoms of Three Micrurus Species

  2024cites this paper
• Snakebite-associated thrombotic microangiopathy: a spotlight on pharmaceutical interventions

  2023cites this paper
• Immunoprofiling of Equine Plasma against Deinagkistrodon acutus in Taiwan: Key to Understanding Differential Neutralization Potency in Immunized Horses

  2023cites this paper
• Immunorecognition and Neutralization of Crotalus durissus cumanensis Venom by a Commercial Antivenom Produced in Colombia

  2022cites this paper
• Antivenom: An immunotherapy for the treatment of snakebite envenoming in sub-Saharan Africa.

  2022cites this paper
• Antivenom availability, delays and use in Australia

  2022cites this paper
• Intraspecific Differences in the Venom of Crotalus durissus cumanensis from Colombia

  2022cites this paper
• Mutual enlightenment: A toolbox of concepts and methods for integrating evolutionary and clinical toxinology via snake venomics and the contextual stance

  2021cites this paper
• Toxicosis of Snake, Scorpion, Honeybee, Spider, and Wasp Venoms: Part 1

  2021cites this paper
• Cloning and Expression of N-CFTX-1 Antigen from Chironex fleckeri in Escherichia coli and Determination of Immunogenicity in Mice

  2021cites this paper
• BITES study: A qualitative analysis among emergency medicine physicians on snake envenomation management practices

  2021cites this paper
• Comparison of the Effectiveness, the Safety, and the Pharmacokinetic of Snakebites Antivenoms: Review

  2020cites this paper
• Scorpion envenomation

  2020cites this paper
• Tedavide kullanılan iki tip polivalan yılan antivenomunun karşılaştırılması

  2020cites this paper
• Comparison of two types of polyvalent snake antivenom used in treatment Tedavide kullanılan iki tip polivalan yılan antivenomunun karşılaştırılması

  2020cites this paper
• Snakebite associated thrombotic microangiopathy: a systematic review of clinical features, outcomes, and evidence for interventions including plasmapheresis

  2020cites this paper
• Phospholipase A2 (PLA2) as an Early Indicator of Envenomation in Australian Elapid Snakebites (ASP-27)

  2020cites this paper
• Snakebites in Suriname: Evaluation of the Protocolled Administration of Anti-Snake Venom in a Tertiary Care Setting.

  2020cites this paper
• The Attitudes of Emergency Physicians in Turkey towards the Snakebites

  2020cites this paper
• زیر همسانه سازی و بیان آنتی ژن کایمر C-CFTX1-STxB زهر عروس دریایی و بررسی آنتی ژنیسیتی آن در موش سوری

  2020cites this paper
• The Urgent Need to Develop Novel Strategies for the Diagnosis and Treatment of Snakebites

  2019cites this paper
• Analysis of effectiveness of Iranian snake antivenom on Viper venom induced effects including analysis of immunologic biomarkers in the Echis carinatus sochureki envenomed victims

  2019cites this paper
• Venomous spider bites in south africa: epidemiology and clinical features

  2019cites this paper
• Risk factor, monitoring, and treatment for snakebite induced coagulopathy: a multicenter retrospective study

  2019cites this paper
• Chapter 213: Marine Trauma and Envenomation

  2019cites this paper
• Developing Modern Pain Therapies

  2019cites this paper
• Risk factor, monitoring, and treatment for snakebite induced coagulopathy: a multicenter retrospective study

  2019cites this paper
• Subcloning and Expression of the Chimeric Antigen C-CFTX1-STxB of the Jellyfish Venom and its Antigenicity Assessment in Syrian Mice

  2019cites this paper
• Immunogenicity of N-CfTX-2 Antigen of Chironex fleckeri Jellyfish in Mice

  2018cites this paper
• Addressing the global challenge of snake envenoming.

  2018cites this paper
• Pharmacodynamics and pharmacokinetics of snake antivenom

  2018cites this paper
• Calculation of effective dose fifty (ED50) of antivenom for American pit viper envenomation

  2018cites this paper
• Catch a tiger snake by its tail: Differential toxicity, co-factor dependence and antivenom efficacy in a procoagulant clade of Australian venomous snakes.

  2017influential citation
• Australian Chirodropid Cubozoan Jellyfish Envenomation

  2017cites this paper
• Treatments for Latrodectism—A Systematic Review on Their Clinical Effectiveness

  2017cites this paper
• Unraveling the Proteome Composition and Immuno-profiling of Western India Russell's Viper Venom for In-Depth Understanding of Its Pharmacological Properties, Clinical Manifestations, and Effective Antivenom Treatment.

  2017cites this paper
• Antivenom for Neuromuscular Paralysis Resulting From Snake Envenoming

  2017cites this paper
• Heterodimeric V. nikolskii phospholipases A2 induce aggregation of the lipid bilayer

  2017cites this paper
• Australian elapid snake envenomation in cats: Clinical priorities and approach

  2017cites this paper
• Efficacy of Indian polyvalent snake antivenoms against Sri Lankan snake venoms: lethality studies or clinically focussed in vitro studies

  2016cites this paper
• Geographical venom variations of the Southeast Asian monocled cobra (Naja kaouthia): venom-induced neuromuscular depression and antivenom neutralization.

  2016cites this paper
• Australian and Pacific Snakes

  2016cites this paper
• Adsorbed plasma proteins modulate the effects of single-walled carbon nanotubes on neutrophils in blood.

  2016cites this paper
• Hematologic effects and complications of snake envenoming.

  2015cites this paper
• Intracranial haemorrhages associated with venom induced consumption coagulopathy in Australian snakebites (ASP-21).

  2015cites this paper
• Snake antivenom for snake venom induced consumption coagulopathy.

  2015cites this paper
• Identification of Allergens in the Box Jellyfish Chironex yamaguchii That Cause Sting Dermatitis

  2015cites this paper
• Randomized controlled trial of intravenous antivenom versus placebo for latrodectism: the second Redback Antivenom Evaluation (RAVE-II) study.

  2014cites this paper
• Viper and Cobra Venom Neutralization by Alginate Coated Multicomponent Polyvalent Antivenom Administered by the Oral Route

  2014cites this paper
• Wilderness medicine.

  2014cites this paper
• Current Treatment for Venom-Induced Consumption Coagulopathy Resulting from Snakebite

  2014cites this paper
• Analysis of Fang Puncture Wound Patterns in Isfahan Province’s, Iran, Venomous and Non-Venomous Snakes

  2014cites this paper
• Detection of venom-antivenom (VAV) immunocomplexes in vitro as a measure of antivenom efficacy.

  2014influential citation
• Engineering Venom’s Toxin-Neutralizing Antibody Fragments and Its Therapeutic Potential

  2014cites this paper
• Diagnostic 20-min whole blood clotting test in Russell's viper envenoming delays antivenom administration.

  2013cites this paper
• Antivenom therapy of carpet viper (Echis ocellatus) envenoming: effectiveness and strategies for delivery in West Africa.

  2013cites this paper
• Neurotoxicity in Snakebite—The Limits of Our Knowledge

  2013cites this paper
• 136 – Injurious Arthropods

  2013cites this paper
• Albumin reduces thrombogenic potential of single-walled carbon nanotubes.

  2013cites this paper
• The standard mouse assay of anti-venom quality does not measure antibodies neutralising the haemorrhagic activity of Vipera ammodytes venom.

  2012cites this paper
• Clinical Effects and Antivenom Dosing in Brown Snake (Pseudonaja spp.) Envenoming — Australian Snakebite Project (ASP-14)

  2012cites this paper
• The seven-year rule for safer prescribing

  2012cites this paper
• Meta-analysis of controlled studies on immunotherapy in severe scorpion envenomation

  2011cites this paper
• Factors associated with difficulty achieving initial control with crotalidae polyvalent immune fab antivenom in snakebite patients.

  2011cites this paper
• Clinical Toxinology

  2011cites this paper
• Hand and Wrist Osteomyelitis and septic arthritis of the hand and wrist

  2010cites this paper
• Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.

  2010cites this paper
• To Study Clinical Presentation, Management, Complications and Outcome in Snake Bite Patients

  year unknowncites this paper